ID

41079

Description

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01421862

Link

https://clinicaltrials.gov/show/NCT01421862

Keywords

  1. 6/20/20 6/20/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 20, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia NCT01421862

Eligibility Leukemia NCT01421862

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01421862
Criteria
Description

Criteria

samples from previously untreated non-m3 acute myeloid leukemia (aml)
Description

Specimen AML Untreated | Exception Acute Promyelocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1,1]
C0370003
UMLS CUI [1,2]
C0023467
UMLS CUI [1,3]
C0332155
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0023487
normal karyotype (nk) intermediate-risk disease
Description

Normal karyotype | Disease Intermediate Risk

Data type

boolean

Alias
UMLS CUI [1]
C0333684
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C3640764
two or more vials of cryopreserved pretreatment bone marrow cells and/or two or more vials of cryopreserved pretreatment blood cells available from the intergroup aml repository
Description

Bone Marrow Cells Pretreatment Cryopreserved | Blood Cells Pretreatment Cryopreserved

Data type

boolean

Alias
UMLS CUI [1,1]
C0005955
UMLS CUI [1,2]
C3539075
UMLS CUI [1,3]
C0010405
UMLS CUI [2,1]
C0005773
UMLS CUI [2,2]
C3539075
UMLS CUI [2,3]
C0010405
blast count ≥ 60%
Description

Blast count

Data type

boolean

Alias
UMLS CUI [1]
C0523113
eligible and evaluable for the patient's clinical trial, and did not have fatal induction toxicity
Description

Eligibility Clinical Trial | Evaluable Patient Clinical Trial | Toxicity Fatal Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C1548635
UMLS CUI [1,2]
C0008976
UMLS CUI [2,1]
C2986511
UMLS CUI [2,2]
C0008976
UMLS CUI [3,1]
C0600688
UMLS CUI [3,2]
C1302234
UMLS CUI [3,3]
C0332197
response to protocol induction chemotherapy:
Description

Response Induction Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1704632
UMLS CUI [1,2]
C3179010
non-response: aml with failure to achieve a complete remission (cr) after induction chemotherapy ("7 & 3"-based therapy using cytatabine and/or daunorobicin hydrochloride (dnr) or idarubicin and/or dnr
Description

Therapy non-responder | Complete remission failed | Status post Induction Chemotherapy | Cytarabine | Daunorubicin Hydrochloride | Idarubicin

Data type

boolean

Alias
UMLS CUI [1]
C0919875
UMLS CUI [2,1]
C0677874
UMLS CUI [2,2]
C0231175
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C3179010
UMLS CUI [4]
C0010711
UMLS CUI [5]
C0282123
UMLS CUI [6]
C0020789
responders: continued complete remission (ccr) > 2 years
Description

Therapy responder | Continued Complete Response

Data type

boolean

Alias
UMLS CUI [1]
C0919876
UMLS CUI [2]
C2347861
patient characteristics:
Description

Patient Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
not specified
Description

Unspecified

Data type

boolean

Alias
UMLS CUI [1]
C0205370
prior concurrent therapy:
Description

Prior Therapy Concurrent

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0205420
see disease characteristics
Description

ID.12

Data type

boolean

Similar models

Eligibility Leukemia NCT01421862

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01421862
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Specimen AML Untreated | Exception Acute Promyelocytic Leukemia
Item
samples from previously untreated non-m3 acute myeloid leukemia (aml)
boolean
C0370003 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0023487 (UMLS CUI [2,2])
Normal karyotype | Disease Intermediate Risk
Item
normal karyotype (nk) intermediate-risk disease
boolean
C0333684 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
Bone Marrow Cells Pretreatment Cryopreserved | Blood Cells Pretreatment Cryopreserved
Item
two or more vials of cryopreserved pretreatment bone marrow cells and/or two or more vials of cryopreserved pretreatment blood cells available from the intergroup aml repository
boolean
C0005955 (UMLS CUI [1,1])
C3539075 (UMLS CUI [1,2])
C0010405 (UMLS CUI [1,3])
C0005773 (UMLS CUI [2,1])
C3539075 (UMLS CUI [2,2])
C0010405 (UMLS CUI [2,3])
Blast count
Item
blast count ≥ 60%
boolean
C0523113 (UMLS CUI [1])
Eligibility Clinical Trial | Evaluable Patient Clinical Trial | Toxicity Fatal Absent
Item
eligible and evaluable for the patient's clinical trial, and did not have fatal induction toxicity
boolean
C1548635 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C2986511 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0600688 (UMLS CUI [3,1])
C1302234 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
Response Induction Chemotherapy
Item
response to protocol induction chemotherapy:
boolean
C1704632 (UMLS CUI [1,1])
C3179010 (UMLS CUI [1,2])
Therapy non-responder | Complete remission failed | Status post Induction Chemotherapy | Cytarabine | Daunorubicin Hydrochloride | Idarubicin
Item
non-response: aml with failure to achieve a complete remission (cr) after induction chemotherapy ("7 & 3"-based therapy using cytatabine and/or daunorobicin hydrochloride (dnr) or idarubicin and/or dnr
boolean
C0919875 (UMLS CUI [1])
C0677874 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C3179010 (UMLS CUI [3,2])
C0010711 (UMLS CUI [4])
C0282123 (UMLS CUI [5])
C0020789 (UMLS CUI [6])
Therapy responder | Continued Complete Response
Item
responders: continued complete remission (ccr) > 2 years
boolean
C0919876 (UMLS CUI [1])
C2347861 (UMLS CUI [2])
Patient Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Prior Therapy Concurrent
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
ID.12
Item
see disease characteristics
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial